J.w. Cole Advisors »

Heron Therapeutics shares owned by J.w. Cole Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by J.w. Cole Advisors from 13F filings

Historical chart of J.w. Cole Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by J.w. Cole Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by J.w. Cole Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 16k 1.26
2025-06-30 $33k 16k 2.07
2025-03-31 $35k 16k 2.20
2024-12-31 $23k 15k 1.53

More positions owned by J.w. Cole Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Div Grwth (DGRO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Exxon Mobil Corporation (XOM)
Vanguard Index Fds Value Etf (VTV)

View all positions for J.w. Cole Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Adage Capital Partners GP
BlackRock
Clearline Capital
Velan Capital Investment Management
Vanguard Group
Palisade Capital Management
Tejara Capital
Baker Bros. Advisors
State Street Corporation
Geode Capital Management
Tang Capital Management
JW Asset Management
D. E. Shaw & Co
UBS Group

View all funds holding Heron Therapeutics